Matches in SemOpenAlex for { <https://semopenalex.org/work/W2398090413> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2398090413 endingPage "3" @default.
- W2398090413 startingPage "40" @default.
- W2398090413 abstract "The chiral lipid regulating agent beclobrate (CAS 55937-99-0), which was marketed as racemate, is - like clofibrate - rapidly hydrolyzed to beclobric acid immediately after absorption. Pharmacokinetic data were only available for the total concentration, but not for the two enantiomers. Therefore, the pharmacokinetics of (-)- and (+)-beclobric acid were studied in 8 healthy male volunteers after a single 100 mg dose of rac-beclobrate and under steady state conditions, i.e. after repetitive dosage of 100 mg beclobrate once daily for 8 days. After oral administration unchanged beclobrate was not detected in plasma. Distinct differences were found in the pharmacokinetic parameters of the two beclobric acid enantiomers. The maximum plasma concentrations and the AUC values of the (+)-enantiomer exceeded those of the (-)-enantiomer nearly 2 fold. Beclobric acid, the active metabolite, is converted to an acyl glucuronide. The diastereomeric glucuronides were detected in the plasma of all volunteers, but the differences in the pharmacokinetics were not as evident as for beclobric acid enantiomers. A comparison of the measured steady-state beclobric acid enantiomer concentration and those simulated on the basis of the parameters (open two-compartment model) obtained for a single beclobrate dose showed that the accumulation factor is slightly but nevertheless significantly higher than predicted." @default.
- W2398090413 created "2016-06-24" @default.
- W2398090413 creator A5047794756 @default.
- W2398090413 creator A5051448005 @default.
- W2398090413 creator A5055370138 @default.
- W2398090413 creator A5058859139 @default.
- W2398090413 date "1993-01-01" @default.
- W2398090413 modified "2023-09-23" @default.
- W2398090413 title "Pharmacokinetics of beclobric acid enantiomers and their conjugates after single and multiple oral dosage of racemic beclobrate." @default.
- W2398090413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8447845" @default.
- W2398090413 hasPublicationYear "1993" @default.
- W2398090413 type Work @default.
- W2398090413 sameAs 2398090413 @default.
- W2398090413 citedByCount "1" @default.
- W2398090413 crossrefType "journal-article" @default.
- W2398090413 hasAuthorship W2398090413A5047794756 @default.
- W2398090413 hasAuthorship W2398090413A5051448005 @default.
- W2398090413 hasAuthorship W2398090413A5055370138 @default.
- W2398090413 hasAuthorship W2398090413A5058859139 @default.
- W2398090413 hasConcept C112705442 @default.
- W2398090413 hasConcept C138716334 @default.
- W2398090413 hasConcept C161790260 @default.
- W2398090413 hasConcept C178790620 @default.
- W2398090413 hasConcept C181389837 @default.
- W2398090413 hasConcept C181647583 @default.
- W2398090413 hasConcept C185592680 @default.
- W2398090413 hasConcept C2777056448 @default.
- W2398090413 hasConcept C2777477808 @default.
- W2398090413 hasConcept C2779186261 @default.
- W2398090413 hasConcept C2779496979 @default.
- W2398090413 hasConcept C43617362 @default.
- W2398090413 hasConcept C486523 @default.
- W2398090413 hasConcept C55493867 @default.
- W2398090413 hasConcept C71240020 @default.
- W2398090413 hasConcept C71924100 @default.
- W2398090413 hasConcept C8171440 @default.
- W2398090413 hasConcept C98274493 @default.
- W2398090413 hasConceptScore W2398090413C112705442 @default.
- W2398090413 hasConceptScore W2398090413C138716334 @default.
- W2398090413 hasConceptScore W2398090413C161790260 @default.
- W2398090413 hasConceptScore W2398090413C178790620 @default.
- W2398090413 hasConceptScore W2398090413C181389837 @default.
- W2398090413 hasConceptScore W2398090413C181647583 @default.
- W2398090413 hasConceptScore W2398090413C185592680 @default.
- W2398090413 hasConceptScore W2398090413C2777056448 @default.
- W2398090413 hasConceptScore W2398090413C2777477808 @default.
- W2398090413 hasConceptScore W2398090413C2779186261 @default.
- W2398090413 hasConceptScore W2398090413C2779496979 @default.
- W2398090413 hasConceptScore W2398090413C43617362 @default.
- W2398090413 hasConceptScore W2398090413C486523 @default.
- W2398090413 hasConceptScore W2398090413C55493867 @default.
- W2398090413 hasConceptScore W2398090413C71240020 @default.
- W2398090413 hasConceptScore W2398090413C71924100 @default.
- W2398090413 hasConceptScore W2398090413C8171440 @default.
- W2398090413 hasConceptScore W2398090413C98274493 @default.
- W2398090413 hasIssue "1" @default.
- W2398090413 hasLocation W23980904131 @default.
- W2398090413 hasOpenAccess W2398090413 @default.
- W2398090413 hasPrimaryLocation W23980904131 @default.
- W2398090413 hasRelatedWork W2016651434 @default.
- W2398090413 hasRelatedWork W2026851037 @default.
- W2398090413 hasRelatedWork W2045222790 @default.
- W2398090413 hasRelatedWork W2073829222 @default.
- W2398090413 hasRelatedWork W2148177218 @default.
- W2398090413 hasRelatedWork W2151296520 @default.
- W2398090413 hasRelatedWork W2318716988 @default.
- W2398090413 hasRelatedWork W2398090413 @default.
- W2398090413 hasRelatedWork W2613078211 @default.
- W2398090413 hasRelatedWork W2948841719 @default.
- W2398090413 hasVolume "43" @default.
- W2398090413 isParatext "false" @default.
- W2398090413 isRetracted "false" @default.
- W2398090413 magId "2398090413" @default.
- W2398090413 workType "article" @default.